Genmab — August 2019
-
Sakset fra fb “I'm 12 cycles (one year) into a clinical study for subcutaneous Dara with Revlimid and Dex. The injections are very smooth at this point. At first, I had a lot of bruising, but there was none the last six or so. I am at one injection per month.”
-
In terms of response, my numbers all-around look great, and I have the lowest level of detectable MM since diagnosis in 2013. I'd surely like to see a zero for m-spike, but I'll take what I can get. M-spike at Dx 7.7, after SCT in 2014 3.0, then 0.1 for five years, slowly increasing to 1.0 before joining this study, now down to 0.1 again.
-
Nye rygter om stor takeover i biotech. Amgen skulle være interesserede i at købe Alexion med 74% premium https://www.investors.com/news/technology/biotech-company-amgen-could-near-deal-acquire-alexion-pharma/?src=A00220&yptr=yahoo er måske med til at stimulere interessen for Genmab
-
Biotech Giant Amgen could be nearing a massive takeover: report. ( investors business Daily ). https://www.investors.com/news/technology/biotech-company-amgen-could-near-deal-acquire-alexion-pharma/
-
Helst ingen bud på Genmab før vi er i kurs 2000
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind